【cats with hyperthyroidism and kidney disease】Cara Therapeutics to Announce First Quarter 2020 Financial Results on May 11, 2020
STAMFORD,cats with hyperthyroidism and kidney disease Conn., May 04, 2020 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (
CARA
), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors, today announced that the Company will host a conference call and live audio webcast on Monday, May 11, 2020, at 4:30 p.m. ET to report first quarter 2020 financial results and provide a corporate update.
To participate in the conference call, please dial (855) 445-2816 (domestic) or (484) 756-4300 (international) and refer to conference ID 3875739. A live webcast of the call can be accessed under “Events & Presentations” in the News & Investors section of the Company’s website at
www.CaraTherapeutics.com
.
An archived webcast recording will be available on the Cara website beginning approximately two hours after the call.
About Cara Therapeutics
Cara Therapeutics is a clinical-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors, or KORs. Cara is developing a novel and proprietary class of product candidates, led by KORSUVA™ (CR845/difelikefalin), a first-in-class KOR agonist that targets the body’s peripheral nervous system, as well as certain immune cells. In two Phase 3 trials, KORSUVA Injection has demonstrated statistically significant reductions in itch intensity and concomitant improvement in quality of life measures in hemodialysis patients with moderate-to-severe chronic kidney disease-associated pruritus (CKD-aP). Oral KORSUVA is in Phase 2 trials for the treatment of pruritus in patients with CKD, atopic dermatitis and primary biliary cholangitis (PBC).
The FDA has conditionally accepted KORSUVA™ as the trade name for difelikefalin injection. CR845/difelikefalin is an investigational drug product and its safety and efficacy have not been fully evaluated by any regulatory authority.
MEDIA CONTACT:
Annie Starr
6 Degrees
973-415-8838
INVESTOR CONTACT:
Jane Urheim
Stern Investor Relations, Inc.
212-362-1200
View comments
(责任编辑:Knowledge)
- The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of FITB, BBBY and IQ
- Can We See Significant Institutional Ownership On The Ceconomy AG (FRA:CEC) Share Register?
- Is Schwab MarketTrack Growth Investor (SWHGX) a Strong Mutual Fund Pick Right Now?
- What Investors Should Know About The Timken Company’s (NYSE:TKR) Financial Strength
- WRAPUP 1-Standard U.S. economic weapons may be inadequate for coronavirus crisis
- Ferro (FOE) Beats Q3 Earnings and Revenue Estimates
- Should We Be Delighted With TCPL Packaging Limited’s (NSE:TCPLPACK) ROE Of 12%?
- The 1750 HP SSC Tuatara Prototype Runs and Can Move
- The Capital Case That Generated the ‘Chip Smith' Instruction
- INVESTOR ALERT: Kirby McInerney LLP Continues Investigation of Shareholder Claims Against Hallmark Financial Services Inc.
- Qatar GDP growth accelerates to 2.2 pct y/y in Q3
- Should You Be Pleased About The CEO Pay At PCM, Inc.’s (NASDAQ:PCMI)
- Fortnite's Season 8 Is Here—and There Be Pirates
-
Freedom Trail and Black Heritage Trail Bring History Into Homes Near and Far
Freedom Trail® Official Historic Sites, Museum of African American History, and Freedom Trail Founda ...[详细] -
Four Business Trends Likely to Affect Your Corporate Legal Team in 2019
Group of business partner looking for the future. Concept of corporate and startupAs we move toward ...[详细] -
Wyoming will investigate CenturyLink internet outage
CHEYENNE, Wyo. (AP) -- Wyoming regulators said they will investigate problems with 911 calls in thei ...[详细] -
Is Humana (HUM) Outperforming Other Medical Stocks This Year?
Investors focused on the Medical space have likely heard of Humana (HUM), but is the stock performin ...[详细] -
SNX or GWRE: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Business - Software Services sector have probably already he ...[详细] -
DLA Piper revenue grows 5% as firm cites knock-on effects of cyber attack
DLA Piper's non-US turnover grew 5% last year, with the firm stating it is still seeing the knock-on ...[详细] -
Kellie Pickler shaves her head: PHOTO
PHOTO: Kellie Pickler shaves her headDon’t worry, she hasn’t pulled a Britney.Country star Kellie Pi ...[详细] -
Cynthia Bailey & Mike Hill Had the Cutest “Date Day” in Matching Yellow Outfits
Cynthia BaileyandMike Hillenjoyed a recent “date day” in style.The Real Housewives of Atlantaalum an ...[详细] -
LOS ANGELES, CA / ACCESSWIRE / March 1, 2020 /The Schall Law Firm, a national shareholder rights lit ...[详细]
-
Colbert Figures Out How to Make Coronavirus Quarantine Feel Like a Vacation, Literally (Video)
We’re in week three of this pandemic shut down now and we’re all getting a little bored — especially ...[详细]
BRIEF-My Heart Bodibra Group Ltd Sees Increase In Loss For Nine Months
RBI governor wanted to step down months before resignation: Modi
- As Currency Values Deflate, Gold Sees Bright Horizon
- 10 Top Stock Picks From the Street’s Best Analysts
- What's in a name? Islamic banking rebrands in attempt to go mainstream
- BRIEF-Inner Mongolia Xingye Mining Buys Back Company's Shares Worth 199.9 Mln Yuan
- Expanse Integrates with ServiceNow
- GBP/USD Forecast: Triple Troubles Pound the Pound
- BRIEF-Zhengzhou Yutong Bus Says It Sold 5,265 Buses In Jan, Up 23.2 Percent Y/Y